D-1334-2022 Class III Terminated
FDA drug recall D-1334-2022 was initiated by Teva Pharmaceuticals USA Inc on Jul 22, 2022 and is designated Class III. Reason for recall: Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification. The recall status is terminated (terminated Apr 12, 2023). Affected quantity: 4162 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 17, 2022
- Initiation Date
- Jul 22, 2022
- Termination Date
- Apr 12, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4162 cartons
Product description
Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56
Reason for recall
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
Distribution pattern
Distributed in Ohio
Code information
Lot: FE22001A, Exp 01/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1334-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026